What question did this study set out to answer?

The research aims to explore the therapeutic potential of CAR-engineered mesenchymal stem cells in treating pre-eclampsia by enhancing immune functions and placental repair.

April 12, 2026

Potential of Chimeric Antigen Receptor‐Engineered Mesenchymal Stem Cell (CAR‐MSC) Therapy in the Treatment of Pre‐Eclampsia

Puntos clave

The research aims to explore the therapeutic potential of CAR-engineered mesenchymal stem cells in treating pre-eclampsia by enhancing immune functions and placental repair.
Investigation of chimeric antigen receptor technology in non-tumor contexts.
Evaluation of CAR-MSCs' effects on placental immune modulation.
Assessment of safety considerations in pregnant populations.
CAR-MSCs may modulate immune function in the placenta.
Potential enhancement of placental repair suggested by preliminary findings.

Resumen

Although non-tumor research based on CAR technology is still in its early stages, in-depth investigation into CAR-MSCs may offer novel insights and perspectives for the treatment of PE by modulating placental immune function and enhancing placental repair. Given that pregnant women constitute a special population, safety considerations must be fully prioritized in future research.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Yixiao Wang

Huan Huang

Ruizhe null Jia

Journals

American Journal of Reproductive Immunology

Actions

Institutions

Zhongda Hospital Southeast University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Potential of Chimeric Antigen Receptor‐Engineered Mesenchymal Stem Cell (CAR‐MSC) Therapy in the Treatment of Pre‐Eclampsia

Puntos clave

Resumen

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study